Forecasts for China and other Emerging Markets have continued on a downtrend, extending last year’s underperformance, meaning investors might want to look into regions with a more favorable outlook.

Jonathan Garner: Looking for Alternatives to Emerging Markets

Short, thoughtful and regular takes on recent events in the markets from a variety of perspectives and voices within Morgan Stanley.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

With interest in anti-obesity medications growing significantly, the head of our European Pharmaceuticals Team examines just how large that market could become.

Meeting the Demand for Anti-Obesity Treatment

As the US presidential election remains closely contested, our experts discuss what a change in administration could mean for European equities in terms of trade, China relations and other key issues.

European Markets React to Upcoming U.S. Election

New data on both immigration and inflation defied predictions and may have shifted the Fed’s perspective.

US Economy: Bigger, But Not Tighter

Recent data indicates the economy may avoid either a soft or hard landing for now. Our Chief U.S. Equity Strategist explains why investors should seek out quality as the economy stays aloft.

U.S. Equities: No Landing in Sight

Japan and India are currently set to lead growth in these markets, but a higher-for-longer rate environment in the U.S. could favor China, Hong Kong and others, according to our analyst.

Jonathan Garner: Looking for Alternatives to Emerging Markets

Download our free app to listen on your phone